Interestingly, the TNBC assay does recognise the other breast subtypes with high frequency with 66% positive for Her2 tumours (31 samples), 46% positive for Luminal A tumours (288 samples) and 63% positive for Luminal B tumours (127 samples) (Supplementary Table 1). Here, ERBB2 is linked to neoplasm.